AGIO logo

Agios Pharmaceuticals, Inc. (AGIO) Cash From Operations

Annual CFO:

-$389.84M-$93.78M(-31.68%)
December 31, 2024

Summary

  • As of today, AGIO annual cash from operations is -$389.84 million, with the most recent change of -$93.78 million (-31.68%) on December 31, 2024.
  • During the last 3 years, AGIO annual cash from operations has risen by +$17.48 million (+4.29%).
  • AGIO annual cash from operations is now -1110.95% below its all-time high of $38.56 million, reached on December 31, 2016.

Performance

AGIO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOcash flow metrics

Quarterly CFO:

-$77.12M+$34.37M(+30.82%)
June 30, 2025

Summary

  • As of today, AGIO quarterly cash from operations is -$77.12 million, with the most recent change of +$34.37 million (+30.82%) on June 30, 2025.
  • Over the past year, AGIO quarterly cash from operations has dropped by -$4.54 million (-6.25%).
  • AGIO quarterly cash from operations is now -148.87% below its all-time high of $157.82 million, reached on June 30, 2016.

Performance

AGIO Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOcash flow metrics

TTM CFO:

-$406.00M-$4.54M(-1.13%)
June 30, 2025

Summary

  • As of today, AGIO TTM cash from operations is -$406.00 million, with the most recent change of -$4.54 million (-1.13%) on June 30, 2025.
  • Over the past year, AGIO TTM cash from operations has dropped by -$99.41 million (-32.43%).
  • AGIO TTM cash from operations is now -586.39% below its all-time high of $83.47 million, reached on June 30, 2016.

Performance

AGIO TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AGIO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-31.7%-6.3%-32.4%
3Y3 Years+4.3%-3.9%-19.0%
5Y5 Years-5.2%-13.8%-21.2%

AGIO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-31.7%+4.3%-25.1%+42.1%-40.1%at low
5Y5-Year-34.1%+4.3%-56.1%+42.1%-40.1%+0.3%
All-TimeAll-Time-1111.0%+4.3%-148.9%+42.1%-586.4%+0.3%

AGIO Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$77.12M(+30.8%)
-$406.00M(-1.1%)
Mar 2025
-
-$111.49M(+16.3%)
-$401.46M(-3.0%)
Dec 2024
-$389.84M(-31.7%)
-$133.17M(-58.1%)
-$389.84M(-18.4%)
Sep 2024
-
-$84.22M(-16.0%)
-$329.16M(-7.4%)
Jun 2024
-
-$72.59M(+27.3%)
-$306.59M(-1.9%)
Mar 2024
-
-$99.87M(-37.8%)
-$300.75M(-1.6%)
Dec 2023
-$296.06M(+4.3%)
-$72.49M(-17.6%)
-$296.06M(-2.2%)
Sep 2023
-
-$61.64M(+7.6%)
-$289.74M(+3.2%)
Jun 2023
-
-$66.75M(+29.9%)
-$299.44M(+2.4%)
Mar 2023
-
-$95.18M(-43.9%)
-$306.93M(+0.8%)
Dec 2022
-$309.48M(+24.0%)
-$66.16M(+7.3%)
-$309.48M(+5.5%)
Sep 2022
-
-$71.35M(+3.9%)
-$327.41M(+4.1%)
Jun 2022
-
-$74.23M(+24.1%)
-$341.24M(+11.2%)
Mar 2022
-
-$97.73M(-16.2%)
-$384.31M(+5.7%)
Dec 2021
-$407.32M(-40.1%)
-$84.09M(+1.3%)
-$407.32M(-9.3%)
Sep 2021
-
-$85.18M(+27.4%)
-$372.62M(-4.8%)
Jun 2021
-
-$117.29M(+2.9%)
-$355.65M(-16.2%)
Mar 2021
-
-$120.75M(-144.4%)
-$306.15M(-5.3%)
Dec 2020
-$290.76M(+21.5%)
-$49.40M(+27.6%)
-$290.76M(+13.2%)
Sep 2020
-
-$68.21M(-0.6%)
-$334.97M(+4.9%)
Jun 2020
-
-$67.80M(+35.7%)
-$352.36M(+5.5%)
Mar 2020
-
-$105.36M(-12.5%)
-$372.71M(-0.6%)
Dec 2019
-$370.62M(-21.7%)
-$93.61M(-9.4%)
-$370.62M(-5.5%)
Sep 2019
-
-$85.59M(+2.9%)
-$351.20M(-6.6%)
Jun 2019
-
-$88.15M(+14.6%)
-$329.45M(-6.7%)
Mar 2019
-
-$103.27M(-39.2%)
-$308.69M(-1.4%)
Dec 2018
-$304.42M
-$74.19M(-16.2%)
-$304.42M(+0.1%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$63.84M(+5.3%)
-$304.69M(+4.4%)
Jun 2018
-
-$67.39M(+31.9%)
-$318.56M(-2.7%)
Mar 2018
-
-$99.00M(-33.0%)
-$310.16M(-8.7%)
Dec 2017
-$285.23M(-839.7%)
-$74.45M(+4.2%)
-$285.23M(-8.9%)
Sep 2017
-
-$77.72M(-31.7%)
-$262.00M(-12.3%)
Jun 2017
-
-$58.99M(+20.4%)
-$233.32M(-1313.8%)
Mar 2017
-
-$74.07M(-44.6%)
-$16.50M(-142.8%)
Dec 2016
$38.56M(+150.1%)
-$51.22M(-4.5%)
$38.56M(-34.9%)
Sep 2016
-
-$49.03M(-131.1%)
$59.26M(-29.0%)
Jun 2016
-
$157.82M(+930.3%)
$83.47M(+218.6%)
Mar 2016
-
-$19.01M(+37.7%)
-$70.37M(+8.5%)
Dec 2015
-$76.95M(-29.6%)
-$30.53M(-23.0%)
-$76.95M(-42.0%)
Sep 2015
-
-$24.82M(-723.5%)
-$54.20M(-2.6%)
Jun 2015
-
$3.98M(+115.6%)
-$52.85M(+8.7%)
Mar 2015
-
-$25.59M(-229.1%)
-$57.90M(+2.5%)
Dec 2014
-$59.35M(-5.2%)
-$7.78M(+66.9%)
-$59.35M(+9.0%)
Sep 2014
-
-$23.47M(-2091.1%)
-$65.19M(-15.0%)
Jun 2014
-
-$1.07M(+96.0%)
-$56.71M(+20.6%)
Mar 2014
-
-$27.04M(-98.6%)
-$71.46M(-26.7%)
Dec 2013
-$56.40M(-13.8%)
-$13.62M(+9.1%)
-$56.40M(-3.7%)
Sep 2013
-
-$14.98M(+5.3%)
-$54.41M(-38.0%)
Jun 2013
-
-$15.82M(-32.1%)
-$39.43M(-15.4%)
Mar 2013
-
-$11.98M(-3.0%)
-$34.16M(+10.5%)
Dec 2012
-$49.55M(-225.6%)
-$11.63M(-10.3%)
-$38.15M(-43.8%)
Jun 2012
-
-$10.55M(+34.0%)
-$26.52M(-66.0%)
Mar 2012
-
-$15.97M
-$15.97M
Dec 2011
-$15.22M
-
-

FAQ

  • What is Agios Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is Agios Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is Agios Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is Agios Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of AGIO is -$389.84M

What is the all-time high annual cash from operations for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high annual cash from operations is $38.56M

What is Agios Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, AGIO annual cash from operations has changed by -$93.78M (-31.68%)

What is Agios Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of AGIO is -$77.12M

What is the all-time high quarterly cash from operations for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high quarterly cash from operations is $157.82M

What is Agios Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, AGIO quarterly cash from operations has changed by -$4.54M (-6.25%)

What is Agios Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of AGIO is -$406.00M

What is the all-time high TTM cash from operations for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high TTM cash from operations is $83.47M

What is Agios Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, AGIO TTM cash from operations has changed by -$99.41M (-32.43%)
On this page